Digital Immunity, with the slogan "Realtime Bioinformatic Cybersecurity Solutions," is a cybersecurity company founded in 2007 and headquartered in Burlington, MA. This United States-based company received a $117.16K Seed Round investment on 27 October 2010.
Specializing in Cyber Security, Enterprise Software, and Information Technology, Digital Immunity aims to revolutionize cyber-threat protection by bridging the gap between real-time threat prevention and 24/7, mission critical environments. It prioritizes security without compromising production, offering advanced cyber-threat prevention in Operational Technology and controlled, mission-critical IT environments, with no impact on production or system performance.
One of the key innovations by Digital Immunity is its patented Digital DNA Mapping technology, which prevents advanced threats such as APT’s and zero-day attacks from executing in memory at runtime, thus hardening mission-critical operating systems and applications. The company also provides a Control Center that enables real-time actionable alerts and forensics artifacts in context, mobilizing security teams effectively.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | $117.16K | - | 27 Oct 2010 | |
Venture Round | $410.00K | - | 17 Oct 2009 |
No recent news or press coverage available for Digital Immunity.